TG Therapeutics Inc (TGTX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Michael Sean Weiss
Employees:
105
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY 10014
(212) 554-4484

TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. It also involves developing TG-1101 and TGR-1202 therapies targeting hematological malignancies. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY.

Data derived from most recent annual or quarterly report
Market Cap 628.396 Million Shares Outstanding142.817 Million Avg 30-day Volume 4.363 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-2.63
Price to Revenue161.5456 Debt to Equity0.3947 EBITDA-317.848 Million
Price to Book Value7.5015 Operating Margin-4075.3286000000003 Enterprise Value1.065 Billion
Current Ratio4.432 EPS Growth0.068 Quick Ratio4.283
1 Yr BETA 2.2236 52-week High/Low 41.0 / 3.48 Profit Margin-4126.4661
Operating Cash Flow Growth-21.0574 Altman Z-Score-3.3927 Free Cash Flow to Firm -231.106 Million
Earnings Report2022-08-01
View SEC Filings from TGTX instead.

View recent insider trading info

Funds Holding TGTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TGTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-06-23:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-18:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-01:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-27:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-04:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-30:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-02:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-06-23:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2021-06-21:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    POWER SEAN A CFO, SECRETARY AND TREASURER

    • Officer
    568,483 2022-01-04 1

    WEISS MICHAEL S CEO AND PRESIDENT

    • Officer
    • Director
    24,443,718 2021-12-29 1

    CHARNEY LAURENCE N

    • Director
    220,997 2021-06-18 0

    ECHELARD YANN

    • Director
    149,116 2021-06-18 0

    HOBERMAN KENNETH

    • Director
    178,953 2021-06-18 0

    HUME DANIEL

    • Director
    154,507 2021-06-18 0

    LONIAL SAGAR

    • Director
    85,000 2021-06-18 0

    LFB BIOTECHNOLOGIES S.A.S.U.

    • 10% Owner
    7,614,855 2015-02-17 0

    HERSKOWITZ NEIL

    • Director
    51,265 2012-12-06 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    TG THERAPEUTICS INC TGTX 2022-06-24 22:15:03 UTC 1.1402 0.4298 2300000
    TG THERAPEUTICS INC TGTX 2022-06-24 21:45:03 UTC 1.1402 0.4298 2300000
    TG THERAPEUTICS INC TGTX 2022-06-24 21:15:04 UTC 1.1402 0.4298 2300000
    TG THERAPEUTICS INC TGTX 2022-06-24 20:45:03 UTC 1.1402 0.4298 2300000
    TG THERAPEUTICS INC TGTX 2022-06-24 20:15:03 UTC 1.1402 0.4298 2300000
    TG THERAPEUTICS INC TGTX 2022-06-24 19:45:03 UTC 1.1402 0.4298 2300000
    TG THERAPEUTICS INC TGTX 2022-06-24 19:15:03 UTC 1.1402 0.4298 2300000
    TG THERAPEUTICS INC TGTX 2022-06-24 18:45:03 UTC 1.1402 0.4298 2300000
    TG THERAPEUTICS INC TGTX 2022-06-24 18:15:04 UTC 1.1402 0.4298 2300000
    TG THERAPEUTICS INC TGTX 2022-06-24 17:45:03 UTC 1.1402 0.4298 2300000
    TG THERAPEUTICS INC TGTX 2022-06-24 17:15:03 UTC 1.1402 0.4298 2300000
    TG THERAPEUTICS INC TGTX 2022-06-24 16:45:03 UTC 1.1426 0.4274 2300000
    TG THERAPEUTICS INC TGTX 2022-06-24 16:15:03 UTC 1.1426 0.4274 2300000
    TG THERAPEUTICS INC TGTX 2022-06-24 15:45:03 UTC 1.1426 0.4274 2300000
    TG THERAPEUTICS INC TGTX 2022-06-24 15:15:03 UTC 1.1426 0.4274 2300000
    TG THERAPEUTICS INC TGTX 2022-06-24 14:45:03 UTC 1.143 0.427 2300000
    TG THERAPEUTICS INC TGTX 2022-06-24 14:15:03 UTC 1.143 0.427 2300000
    TG THERAPEUTICS INC TGTX 2022-06-24 13:45:03 UTC 1.143 0.427 2300000
    TG THERAPEUTICS INC TGTX 2022-06-24 13:15:03 UTC 1.143 0.427 2200000
    TG THERAPEUTICS INC TGTX 2022-06-24 12:45:03 UTC 1.143 0.427 2200000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    FundVantage Trust- Gotham Master Neutral Fund TGTX -1.0 shares, $-26.76 2020-09-30 N-PORT
    Trust for Professional Managers- Convergence Long/Short Equity Fund TGTX -1239.0 shares, $-18832.8 2021-11-30 N-PORT
    CLOUGH GLOBAL LONG/SHORT FUND- Clough Global Long/Short Fund TGTX -9280.0 shares, $-107369.6 2022-01-31 N-PORT
    PACE SELECT ADVISORS TRUST- PACE Alternative Strategies Investments TGTX -16450.0 shares, $-190326.5 2022-01-31 N-PORT
    Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund TGTX -19750.0 shares, $-228507.5 2022-01-31 N-PORT
    Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund TGTX -19750.0 shares, $-228507.5 2022-01-31 N-PORT
    RUSSELL INVESTMENT CO- Sustainable Equity Fund TGTX -1252.0 shares, $-14485.64 2022-01-31 N-PORT
    CLOUGH GLOBAL EQUITY FUND- Clough Global Equity Fund TGTX -56480.0 shares, $-653473.6 2022-01-31 N-PORT
    CLOUGH GLOBAL OPPORTUNITIES FUND- Clough Global Opportunities Fund TGTX -105120.0 shares, $-1216238.4 2022-01-31 N-PORT
    FundVantage Trust- Gotham Hedged Plus Fund TGTX -179.0 shares, $-1702.29 2022-03-31 N-PORT
    Trust for Professional Managers- Convergence Long/Short Equity ETF TGTX -1239.0 shares, $-5476.38 2022-05-31 N-PORT
    INVESTMENT MANAGERS SERIES TRUST- 361 Domestic Long/Short Equity Fund TGTX -286.0 shares, $-1984.84 2022-04-30 N-PORT
    INVESTMENT MANAGERS SERIES TRUST- 361 Global Long/Short Equity Fund TGTX -171385.0 shares, $-1189411.9 2022-04-30 N-PORT

    Elevate your investments